Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Pharmacogenetics of P2Y 12 receptor inhibitors

Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy(2023)10.1002/phar.2758Source: DataRank Database

Pharmacogenetics of P2Y 12 receptor inhibitors is a research paper published in Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (2023). On theSindex it has a DataRank of 0. It has been cited 25 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access25 citations

Download PDF

Cite:

Linked data & code

refsnp

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 4.47)OA: greenTopics (39)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Alexis K. Williams ORCID,Craig R. Lee ORCID,Larisa H. Cavallari ORCID,Cameron D. Thomas ORCID

Live enrichment

PubMed:36588476 PMC:PMC9931684 OpenAlex:https://openalex.org/W4313424491

National Center for Advancing Translational Sciences

Grant: UL1TR001427

National Heart, Lung, and Blood Institute

Grant: 1R01HL149752

National Human Genome Research Institute

Grant: U01HG007269

NHLBI NIH HHS

Grant: R01 HL149752

FWCI

4.47

Citation Percentile

1.0%

Citation Trend

2023

2024

2025

2026

greenLicense: cc-by

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC9931684/pdf/nihms-1867376.pdf

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/phar.2758

publisherhttps://onlinelibrary.wiley.com/doi/full-xml/10.1002/phar.2758

publisherhttps://accpjournals.onlinelibrary.wiley.com/doi/pdf/10.1002/phar.2758

Fields of Study

Antiplatelet Therapy and Cardiovascular DiseasesDiabetes Treatment and ManagementSynthesis of β-Lactam CompoundsHumansClopidogrelPlatelet Aggregation InhibitorsTicagrelorPrasugrel HydrochloridePharmacogeneticsPercutaneous Coronary InterventionAcute Coronary SyndromeCytochrome P-450 CYP2C19Purinergic P2Y Receptor AntagonistsTreatment Outcome

MeSH Terms

Prasugrel HydrochlorideClopidogrelTicagrelorHumansPharmacogeneticsPlatelet Aggregation InhibitorsTreatment OutcomeAcute Coronary SyndromePurinergic P2Y Receptor AntagonistsPercutaneous Coronary InterventionCytochrome P-450 CYP2C19

Keywords

PharmacogeneticsReceptorPharmacologyComputational biologyChemistryBiologyGeneticsGenotypeGeneCYP2C19Percutaneous coronary interventionClopidogrelGenetic TestingPrecision Medicine

Sustainable Development Goals

SDG 0: Good health and well-being